Paul Hartmann AG (FRA:PHH2)

Market Cap	742.31M -13.6%
Revenue (ttm)	2.46B +1.4%
Net Income	61.21M -43.6%
EPS	17.23 -43.6%
Shares Out	3.55M
PE Ratio	12.13
Forward PE	n/a
Dividend	8.00 (3.83%)
Ex-Dividend Date	Apr 30, 2026

Volume	5
Average Volume	57
Open	209.00
Previous Close	210.00
Day's Range	209.00 - 209.00
52-Week Range	209.00 - 258.00
Beta	0.52
RSI	36.63
Earnings Date	May 15, 2026

About Paul Hartmann AG

Paul Hartmann AG manufactures and sells medical and care products in Germany, the rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Wound Care, Incontinence Management, and Infection Management. It offers absorbent underwear, incontinence pads and pants, and fixation pants; medical skincare products; wound management products, such as hydro active wound and silicone SAP dressings, post-op dressings, nature care, adhesive fixation, non-adhesive fixation, gauze, sponge...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1818
• Employees: 10,066
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PHH2

Financial Performance

In 2025, Paul Hartmann AG's revenue was 2.46 billion, an increase of 1.37% compared to the previous year's 2.43 billion. Earnings were 61.21 million, a decrease of -43.56%.